1. Advances and prospects of RNA delivery nanoplatforms for cancer therapy
   Mohamed S. Attia et al, 2024, Acta Pharmaceutica Sinica B CrossRef
2. Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial
   Xiaochu Man et al, 2024, Clinical and Translational Medicine CrossRef
3. Toll-like receptors in breast cancer immunity and immunotherapy
   Joseph Zhou et al, 2024, Frontiers in Immunology CrossRef
4. Participation of TLRs in cancer immunopathogenesis and drug resistance via interacting with immunological and/or non-immunological signaling pathways as well as lncRNAs
   Sharif Alhajlah, 2024, International Immunopharmacology CrossRef
5. THIOSTREPTON MODULATES TLR4 EXPRESSION AND INDUCES APOPTOSIS IN MDA MB 231 CELLS: AN IN VITRO AND IN SILICO ANALYSIS
   Funda Demırtaş Korkmaz et al, 2024, Meandros Medical And Dental Journal CrossRef